| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88235670 | FILING DATE | 12/19/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | SPILS, CAROL A |
L.O. ASSIGNED | 104 |
PUB INFORMATION |
|||
| RUN DATE | 06/28/2019 | ||
| PUB DATE | N/A | ||
| STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
| STATUS DATE | 06/27/2019 | ||
| LITERAL MARK ELEMENT | MMT | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | MMT |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Kaleido Biosciences, Inc. |
| ADDRESS | 65 Hayden Avenue Lexington, MA 02421 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | therapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; medical diagnostic reagents and assays for testing body fluids for microorganisms for modifying the microbial composition or metabolic output of the human microbiome |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 06/27/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
| 06/27/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 06/25/2019 | ALIE | A | ASSIGNED TO LIE | 007 |
| 06/19/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 006 |
| 03/22/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 005 |
| 03/22/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 004 |
| 03/22/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 003 |
| 03/14/2019 | DOCK | D | ASSIGNED TO EXAMINER | 002 |
| 01/11/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Christina M. Licursi, Esq. |
| CORRESPONDENCE ADDRESS | CHRISTINA M. LICURSI, ESQ. WOLF GREENFIELD & SACKS, P.C. 600 ATLANTIC AVENUE BOSTON, MA 02210 |
| DOMESTIC REPRESENTATIVE | NONE |